Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of AKT function in human gastric cancer cells.
Lin HL, Chiou SH, Wu CW, Lin WB, Chen LH, Yang YP, Tsai ML, Uen YH, Liou JP, Chi CW. Lin HL, et al. Among authors: Liou JP. J Pharmacol Exp Ther. 2007 Oct;323(1):365-73. doi: 10.1124/jpet.107.124966. Epub 2007 Jul 23. J Pharmacol Exp Ther. 2007. PMID: 17646428
A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY. Liou JP, et al. J Pharmacol Exp Ther. 2007 Oct;323(1):398-405. doi: 10.1124/jpet.107.126680. Epub 2007 Jul 27. J Pharmacol Exp Ther. 2007. PMID: 17660383
119 results
Jump to page
Feedback